Professor of Medicine, Johannes Gutenberg University of Mainz
Biologics in Asthma – are we turning the corner
Director of Human Factors, Team Consulting
Human Factor Considerations in Inhaler Innovation
Chairman of Cardiff Scintigraphics Limited
Next generation formulations for pMDIs
Senior Lecturer and Honorary Consultant Respiratory Physician, University of Manchester
mHealth in asthma – friend or foe
Chief Scientist
Innovations in formulations to improve aerosol delivery
Senior Clinical Lecturer, MRC Centre for Inflammation Research, University of Edinburgh
Multiplexed optical molecular sensing and imaging in the lungs
Polymer-protein-based dry powder for efficient pulmonary protein delivery
In-silico lung modeling platform for inhaled drug delivery
Aspergillus fumigatus in valved holding chambers: use of silver ion additive technology on fungal activity and aerosol delivery characteristics
Multi-physics theoretical approach to predict pMDI spray characteristics
Carrier microstructure and performance of dry powder inhalation mixtures: A step towards universal performance prediction model
Novel techniques for characterising inhalers
Influence of blender type on the performance of ternary dry powder inhaler formulations
Characterisation of MRP1 in human distal lung epithelial cells in vitro
Anti-inflammatory activity of novel trans-stilbene sulfonamide analogues as potential novel therapeutic agents for lung disease
New lung-tumour-penetrating nanocarrier designed for aerosolized chemotherapy
Innovations in nebulized delivery
Development of inhalable drug formulations for idiopathic pulmonary fibrosis
Clinically relevant in vitro tests for the assessment of innovator and generic nasal spray products
Oxytocin receptor expression but a lack of response to oxytocin in airway tissues
Investigating the effect of the force control agent magnesium stearate in fluticasone propionate dry powder inhaled formulations with single particle aerosol mass spectrometry (SPAMS)
